New combo therapy aims to help advanced esophageal cancer patients swallow easier
NCT ID NCT02297217
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 21 times
Summary
This study is for people with advanced esophageal cancer that cannot be cured. It tests whether adding two chemotherapy drugs (carboplatin and paclitaxel) to standard radiation therapy can better relieve trouble swallowing and improve quality of life. About 50 adults with swallowing difficulties will take part. The goal is to see if the combination provides longer-lasting relief from swallowing problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tom Baker Cancer Centre
RECRUITINGCalgary, Alberta, T2N 4N2, Canada
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.